Evicenter
P&T meetings

Imlifidase

Kidney transplantation in highly sensitized patients

Manufacturer
Hansa Biopharma
Regulatory submission
BLA submitted December 2025
Last updated
85 sources

Product information and disease descriptionPlace of product in therapyDisease descriptionBurden of Kidney transplantation in highly sensitized patients

Economic burden and healthcare resource utilization

2 evidence topics · 4 sources

In-center hemodialysis: treatment frequency and duration

“usually three times per week” (opens the source at this quote in a new tab)

“Each dialysis session lasts about 4 hours.” (opens the source at this quote in a new tab)

Irish economic model: probabilistic sensitivity analysis

“dominant versus SoC in 94.5% of model simulations” (opens the source at this quote in a new tab)